By Todd Harrison
I would like to start today's vibe by making a statement: I want to be bullish in here.
I will follow with an old school axiom: Hope is not a viable investment vehicle.
We've dutifully weighed both sides of the market ride, and a few weeks ago offered that The Critter Compass pointed to S&P 1250 (and we got quite close). Still, we'll chew through the dew one more time, for this is perhaps the single most important juncture of the year -- if not, and I'm not prone to hyperbole, history.
Yes,history.
(To read Jeff Harding's thoughts on economic stagnation, click here.)
The bulls will point to the strong corporate credit markets (which suggest higher equity prices despite trading off their best levels) and "The Misery Index," which has hit a 28-year high, as a contrary indicator. They'll use technical terms like "stochastics" and "put/call ratios" to support their thesis, and in a vacuum they're 100% right.
Outside the vacuum, here in the world with the rest of us, we're dancing on the head of a pin and few people seem to notice how precarious our position is. Way back when, during the panic of 2008, we spoke about the lesser of two evils, about how the government bought the cancer in an attempt to sell the car crash.
They were "successful," insofar that they jacked the stock market 100% and allowed corporate America to roll their debt and issue stock. What they also did, perhaps unintentionally, is transfer risk from the private sector to an already burgeoning public sector, and heighten tension in the geopolitical spectrum.
(To read Mike Mish Shedlock's thoughts on stock book values, click here.)
Again, and apologies if this is redundant, there are two paths:
Market News and Data brought to you by Benzinga APIs- Drugs that mask the symptoms (throwing trillions of dollars at the problem), which triggered a spate of unintended consequences (such as out-sized bank profits) and lead to a tricky trifecta of societal acrimony (Goldman Sachs GS, BP BP), social unrest (Greece, Egypt, Libya, Yemen, Syria, Tunisia, Spain), and geopolitical conflicts (yet to be determined).
- Medicine that cures the disease (debt destruction and/or reorganization), which will be a bitter pill to swallow (there are no easy answers) but once we traverse through that process, it'll pave the way to a legitimate outside-in globalization (the US won't lead, but will participate). This, in my view, is where the market was heading before the synthetic stimuli, and it's where the market will ultimately go whether we like it or not (the question, of course, is "from where?").
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: GlobalEconomicsMarketsEnergyEuropeFinancialsIntegrated Oil & GasInvestment Banking & BrokerageS&P
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in